InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Elazzouzi Amy. Director active across 1 company, notably Aura Biosciences, Inc.. Cumulatively, 11 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €76k. History available since 29 October 2024. The latest transaction was filed on 1 September 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Elazzouzi Amy is a declarant linked to Aura Biosciences, Inc., where she is Senior Vice President, Finance. She has 10 filings in total, and across the 10 sampled filings from 2024-10-29 to 2026-03-03, reported sales total 75544 EUR, with the modal transaction nature shown as Cession.